Canada markets closed

Avalo Therapeutics, Inc. (AVTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
14.36-1.54 (-9.69%)
At close: 04:00PM EDT
14.20 -0.16 (-1.11%)
After hours: 05:46PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 14.85M
Enterprise Value 7.97M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.07
Price/Book (mrq)2.03
Enterprise Value/Revenue 4.14
Enterprise Value/EBITDA -0.29

Trading Information

Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change 3-97.57%
S&P500 52-Week Change 322.38%
52 Week High 31,130.40
52 Week Low 33.95
50-Day Moving Average 310.03
200-Day Moving Average 320.02

Share Statistics

Avg Vol (3 month) 3692.58k
Avg Vol (10 day) 373.93k
Shares Outstanding 51.03M
Implied Shares Outstanding 61.03M
Float 8860.98k
% Held by Insiders 15.74%
% Held by Institutions 16.27%
Shares Short (Apr 15, 2024) 4153.4k
Short Ratio (Apr 15, 2024) 40.08
Short % of Float (Apr 15, 2024) 414.83%
Short % of Shares Outstanding (Apr 15, 2024) 414.83%
Shares Short (prior month Mar 15, 2024) 467.18k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:240
Last Split Date 3Dec 29, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-656.92%

Management Effectiveness

Return on Assets (ttm)-53.91%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)1.92M
Revenue Per Share (ttm)6.93
Quarterly Revenue Growth (yoy)-36.30%
Gross Profit (ttm)N/A
EBITDA -23.29M
Net Income Avi to Common (ttm)-31.54M
Diluted EPS (ttm)-114.00
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.42M
Total Cash Per Share (mrq)7.17
Total Debt (mrq)1.9M
Total Debt/Equity (mrq)26.05%
Current Ratio (mrq)1.82
Book Value Per Share (mrq)9.11

Cash Flow Statement

Operating Cash Flow (ttm)-30.68M
Levered Free Cash Flow (ttm)-20.79M